Exelon (EXC) PT Lowered to $52 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EXC Hot Sheet
Price: $46.24 --0%
Rating Summary:
8 Buy, 23 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 19 | New: 2
Rating Summary:
8 Buy, 23 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 19 | New: 2
Join SI Premium – FREE
Morgan Stanley analyst David Arcaro lowered the price target on Exelon (NASDAQ: EXC) to $52.00 (from $54.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Exelon (EXC) PT Raised to $47 at BMO Capital
- Dianthus Therapeutics (DNTH) PT Raised to $134 at Raymond James
- Loop Capital Upgrades Procore Technologies, Inc (PCOR) to Buy, PT $93
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
